AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹108 Cr | ₹79 Cr | ₹71 Cr | - |
What is the latest Deferred Tax Assets / Liabilities ratio of AARTI PHARMALABS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹108 Cr |
Mar2023 | ₹79 Cr |
Mar2022 | ₹71 Cr |
Mar2021 | - |
How is Deferred Tax Assets / Liabilities of AARTI PHARMALABS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹108 Cr | 36.89 | |
Mar2023 | ₹79 Cr | 11.56 | |
Mar2022 | ₹71 Cr | 0 | |
Mar2021 | - | - |
Compare Deferred Tax Assets / Liabilities of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹5,940.2 Cr | -0.1% | 11.4% | 51.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | -0.1% |
11.4% |
51.6% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses